通过新抗原mRNA疫苗对ICI的有效性进行敏感化,用于HCC治疗

Rui Han1,2,3,4, Yuqian Wang1,2, Lingeng Lu4,5,6

  • 1Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China.

Pharmaceutics
|January 23, 2024
PubMed
概括

下一代信使RNA (mRNA) 癌症疫苗显示出免疫治疗的前景,基于COVID-19疫苗的成功. 将mRNA疗法与免疫检查点抑制剂相结合,为治疗和预防肝细胞癌提供了新的希望.